PCR and Real-time PCR Molecular Diagnostics Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030

Published on : Oct-2020 | List of Tables : 37 | List of Figures : 85 | No. of Pages : 170 | Report Code : FACT5247MR |

PCR and Real-time PCR Molecular Diagnostics Market Overview

In recent years, uptake of polymerase chain reaction (PCR) molecular diagnostics has experienced substantial increase. PCR tests are highly effective in detecting pathogenic DNA for several contagious diseases. Efforts are underway to improve the scope of PCR and RT-PCR tests to discover treatments for life-threatening ailments.

The COVID-19 pandemic has especially bolstered prospects for the expansion of the PCR and real-time PCR molecular diagnostics market size. Various healthcare settings have deployed real-time (qPCR) and digital (dPCR) PCR tests to detect and diagnose possible cases. Its highly sensitive nature has led healthcare providers to adopt PCR tests on a large scale. On the back of such trends, the global PCR and real-time PCR molecular diagnostics market is set to reach new heights, surpassing an impressive revenue threshold in the coming decade.

PCR and Real-time PCR Molecular Diagnostics Market: Technology Insights

Real-time PCR tests are likely to retain lucrativeness, attributed to higher sensitivity, timely processing of test results, greater precision, and less prone to contamination, thereby limiting error margins. Uptake of RT-PCR tests has specifically surged amid the COVID-19 pandemic.

Likewise, digital PCR tests are acquiring traction, owing to increasing smart technology penetration across the healthcare sector. Digital PCR tests do not require calibration against standards, an aspect that is important for RT-PCR tests. Moreover, dPCR tests can also detect more samples as opposed to traditional PCR tests.

pcr and real time pcr molecular diagnostics market analysis and forecast by technology

For better understanding of revenue contribution of each technology to the PCR and real-time PCR molecular diagnostics market, ask an expert analyst

PCR and Real-time PCR Molecular Diagnostics Market: Application Insights

Testing for infectious diseases is likely to attain high growth, attributed to high prevalence of sexually-transmitted infections, respiratory infections, and hepatitis C and B, respectively. Immense traction is expected related to this for the PCR and real-time PCR molecular diagnostics market in the wake of the COVID-19 pandemic.

Simultaneously, oncology is touted to emerge as a key application area. Continuous innovations and technological breakthroughs are likely to enhance PCR molecular diagnostics in the detection, diagnosing, and treating cancers on a large scale. An impressive revenue share is projected for the segment in the global PCR and real-time PCR molecular diagnostics market.

PCR and Real-time PCR Molecular Diagnostics Market: Product Insights

Consumables and reagents are likely to remain primary PCR molecular diagnostic products until 2030. The launch of new PCR testing kits in recent years to identify and detect pathogen presence across various end-use industries is uplifting their growth. In 2017, AOAC International granted approval to Bio Rad Laboratories’ iQ-Check (Real-time PCR Kit) as the official Salmonella bacteria detection approach in the meat industry. This development has paved the way for future advanced meat pathogen detection techniques.

PCR and Real-time PCR Molecular Diagnostics Market: End Use Insights

Hospitals will remain the primary PCR molecular diagnostics technology end users, owing to high preference by patients to seek professional treatment. Hospitals possess the necessary qualified personnel capable of conducting such complicated tests and provide precise results. Recently, diagnostic labs and academic and research institutions have also been demanding advanced molecular diagnostics to streamline their research and testing capacities. These settings provide an ideal environment for technicians and students to acquaint themselves with the latest diagnostics technology through trial and error.

Regional Outlook of PCR and Real-time PCR Molecular Diagnostics Market

Regionally, North America is expected to remain highly promising and hold a prominent PCR and real-time PCR molecular diagnostics market share, owing to multiple product launches and a burgeoning healthcare industry. Over the years, regulatory approvals by the FDA have expanded the scope of molecular diagnostics, encouraging vendors to flood the market with advanced PCR testing kits.

A high proportion of the geriatric population and consequent rise in chronic & infectious ailments has broadened growth prospects across Asia Pacific. Timely detection of HIV/AIDS, cancer, and hepatitis CandB have accelerated the need for adopting accurate RT-PCR testing kits across key countries.

PCR and Real-time PCR Molecular Diagnostics Market Trends

Elevated Burden of Infectious and Chronic Ailments: PCR and RT-PCR tests are finding significant ground amid increasing incidence of chronic and infectious diseases. According to WHO, cancer is the leading cause of frailty and deaths around the world, comprising nearly 10 million fatalities in 2018.

RT-PCR tests have therefore proven extremely useful in identifying numerous small tumor cells circulating within the human body. These tests assist in providing accurate prognosis and predict resistance, toxicity, or response to chemotherapy. Likewise, the test is also used to detect HIV/ADIS and Hepatitis C, respectively.

High Demand for Advanced Molecular Diagnostics: With increased complications of chronic and infectious ailments, demand for sophisticated diagnostic tools to address them has taken precedence. Timely detection is important to manage and stem further spread of diseases such as cancer. Clinical benefits such as enhanced sensitivity, broader application, and better turnaround times are accelerating the uptake of advanced molecular diagnostics. Based on this trend, demand for PCR and RT-PCR tests is likely to proliferate in the coming years, bolstering the growth of the PCR and real-time PCR molecular diagnostics market.

pcr and real time pcr molecular diagnostics market competition analysis

For a dashboard view of key players operating in the PCR and real-time PCR molecular diagnostics market, request a report sample

PCR and Real-time PCR Molecular Diagnostics Market: Prominent Players

Fact.MR’s report has profiled the following vendors in the global PCR and real-time PCR molecular diagnostics market:

  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Becton, Dickinson and Company
  • QIAGEN N.V
  • F-Hoffmann-La Roche Ltd.
  • Genomic Health
  • GRIFOLS S.A
  • Thermo Fisher Scientific Inc.
  • Seegene Inc.
  • Hologic Inc.

These players rely on product launches, regulatory approvals, technological advancements, and adoption of advanced molecular diagnostics to remain afloat. Additionally, they also depend on collaborations with other players, governmental agencies, research institutes, and manufacturers to deepen their geographical presence. With the COVID-19 pandemic crisis looming large, manufacturers are directing all their resources towards developing advanced testing kits.

  • Abbott Laboratories, for instance, received an emergency use authorization (EUA) from the U.S. FDA to introduce its RealTime SARS-CoV-2 assay-based on PCR for qualitative nucleic acid detection.
  • In 2017, Danaher Corporation acquired ID Business Solutions Ltd. with the objective of expanding its life sciences business portfolio. Currently, the company is also accelerating PCR testing kit production for health organizations to address the COVID-19 pandemic.
  • In March 2020, Bio Rad Laboratories partnered with testing labs worldwide to develop and implement RT-PCR products for the detection of novel coronavirus. An extensive user of these products is the Assurance Scientific Laboratories in Birmingham, Alabama. It uses Bio-Rad’s CFX384 Touch Real-Time PCR Detection Systems.

The Analyst’s Viewpoint

“Global demand for PCR and RT-PCR diagnostics is anticipated to remain on an upward trajectory even in the post-pandemic scenario. This is largely the outcome of advancements in diagnostic sciences to discover more robust and advanced treatment approaches for multiple ailments.”

Prolific Opportunities Lie Ahead due to COVID-19 Pandemic

The novel coronavirus pandemic has dramatically accelerated the PCR and RT-PCR molecular diagnostics market growth prospects. Manufacturers are accelerating testing kit production to cope with the exponentially surging number of positive cases around the world. Various international agencies such as the World Health Organization, Food and Agricultural Organization, and a host of governmental and non-governmental organizations are lending monetary and policy support to nations to escalate the availability of PCR testing kits.

Real-time PCR testing is highly sensitive and specific, capable of delivering reliable diagnosis in as little as 3 hours. Error margins are significantly reduced as the entire testing process is conducted in a closed tube. Compared to alternative virus isolating isolation techniques, PCR and RT-PCR molecular diagnostics possess lower cross-contamination risks, providing accurate and precise results. Moreover, PCR tests are much faster in terms of test results delivery. As such, the COVID-19 outbreak is accelerating the progress of the global PCR and real-time PCR molecular diagnostics market.

PCR and Real-time PCR Molecular Diagnostics Market: About the Report

Fact.MR has published an exclusive forecast report on the PCR and real-time PCR molecular diagnostics market from 2020 to 2030. The foremost objective of this report is to pitch insights on the market scenario, demand generators, and technological advancements in the PCR and real-time PCR molecular diagnostics market. Also, the study addresses key dynamics that are expected to diversify the sales and future prominence of the market.              

The report begins with an executive overview, in which, product definition has been provided. The report further proceeds with the taxonomy of the PCR and real-time PCR molecular diagnostics market, elaborating on key segments. Also, the report outlines visionary insights on the dynamics of the PCR and real-time PCR molecular diagnostics market, including the drivers, restraints, opportunities, trends, and pricing analysis, along with key buying factors for PCR and real-time PCR molecular diagnostic kits.

PCR and Real-time PCR Molecular Diagnostics Market - Scope of the Report

A new report by Fact.MR on the PCR and real-time PCR molecular diagnostics market provides a 10-year forecast analysis for the period of 2020 to 2030. The study covers key trends that are influencing the growth of the PCR and real-time PCR molecular diagnostics market. This report explicates on key dynamics, including the drivers, restraints, and opportunities for leading market players in addition to major stakeholders and new players associated with the services of PCR and real-time PCR molecular diagnostics. The study also discusses the dynamics responsible for affecting the future of the PCR and real-time PCR molecular diagnostics market over the assessment period.

A detailed scrutiny of PCR and real-time PCR molecular diagnostics business execution, value chain analysis, and supply chain analysis across regional markets has been provided. A list of major companies operating in the PCR and real-time PCR molecular diagnostics market along with their product portfolios boosts the reliability of this research report.

PCR and Real-time PCR Molecular Diagnostics Market: Report Summary

The study offers comprehensive analysis on diverse features, including product developments, demand, sales, and revenue generation in the global PCR and real-time PCR molecular diagnostics market.

An in-depth estimate on the PCR and real-time PCR molecular diagnostics market has been given through optimistic and conservative scenarios, encompassing the sales of PCR and real-time PCR molecular diagnostics during the forecast period. Region-wise price point comparison and data on global average price is also covered in the study.

PCR and Real-time PCR Molecular Diagnostics Market: Segmentation

Fact.MR has studied the PCR and real-time PCR molecular diagnostics market with detailed segmentation on the basis of technology, product, application, end user, and key regions.

Technology

  • Traditional PCR
  • Real-time PCR
  • Digital PCR

Product

  • Instruments
  • Reagents
  • Consumables

Application

  • Infectious Diseases Testing
    • HCV and HBV
    • Sexually Transmitted Infections
    • Hospital Acquired Infection
    • Respiratory Infections
    • Others
  • Oncology Testing
  • Genetic Testing
  • Others
End User
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

PCR and Real-time PCR Molecular Diagnostics Market: Analysis on Market Size Evaluation

The PCR and real-time PCR molecular diagnostics market has been analyzed for each market segment in terms of value (US$ Mn).

Market estimates for global and regional levels for PCR and real-time PCR molecular diagnostics are provided in the report in terms of “US$ Mn” for value. A Y-o-Y growth analysis on major PCR and real-time PCR molecular diagnostics market segments, in addition to an evaluation of market attractiveness, has been added to the report. Also, absolute dollar opportunity analysis of the segments boosts the scope of the report. Absolute dollar opportunity plays a critical role in the assessment of opportunities that manufacturers/distributors can achieve, with the identification of potential resources, covering sales and distribution in the global PCR and real-time PCR molecular diagnostics market.

PCR and Real-time PCR Molecular Diagnostics Market: Inspected Assessment on Regional Segments

Key sections have been elaborated on the PCR and real-time PCR molecular diagnostics market report, in terms of projections for regional markets. These chapters include regional macros (economic, political and business environment), which are projected to notably influence the growth of the PCR and real-time PCR molecular diagnostics market during the forecast period.

Country-specific evaluation for PCR and real-time PCR molecular diagnostics has been given for every regional market, with estimates on market scope and forecasts, impact analysis, and price index of the dynamics in regions and countries. Y-o-Y estimates have been added for all regional markets. Detailed analysis in terms of value and volume for emerging regional markets have also been added to the report.

PCR and Real-time PCR Molecular Diagnostics Market: In-depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of PCR and real-time PCR molecular diagnostics, along with detailed profiles. Important and up-to-date information related to market performers who are largely engaged in the services of PCR and real-time PCR molecular diagnostics has been discussed with the aid of a detailed dashboard view. Market share analysis and comparison of the top players allows report readers to take preemptive steps in boosting their businesses.

Company profiles have been added, including essential data on key strategies and product portfolios along with a comprehensive SWOT analysis. Company presence is mapped through a matrix for major players, providing readers with actionable insights on market status and prediction of the competition level in the PCR and real-time PCR molecular diagnostics market. Prominent companies operating in the global PCR and real-time PCR molecular diagnostics market include Abbott Laboratories, bioMereieux SA, Elekta AB Bio-Rad Laboratories Inc., Danaher Corporation, Thermo Fisher Scientific Inc., and Hologic Inc., among others.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR and Real-time PCR Molecular Diagnostics Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global PCR and Real-time PCR Molecular Diagnostics Market Analysis and Forecast, 2020-2030

5. Market Outlook

    5.1. Technology Advancement

    5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)

    5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology

    6.1. Introduction and Definition

    6.2. Global PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        6.2.1. Traditional PCR

        6.2.2. Real-time PCR

        6.2.3. Digital PCR

    6.3. Global PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology

7. Global PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product

    7.1. Introduction and Definition

    7.2. Global PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        7.2.1. Instruments

        7.2.2. Reagents

        7.2.3. Consumables

    7.3. Global PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product

8. Global PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn)  Forecast, by Application

    8.1. Introduction and Definition

    8.2. Global PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        8.2.1. Infectious Diseases Testing

            8.2.1.1. HCV and HBV

            8.2.1.2. Sexually Transmitted Infections

            8.2.1.3. Hospital Acquired Infection

            8.2.1.4. Respiratory Infections

            8.2.1.5. Others

        8.2.2. Oncology Testing

        8.2.3. Genetic Testing

        8.2.4. Others

    8.3. Global PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application

9. Global PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user

    9.1. Introduction and Definition

    9.2. Global PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2020-2030

        9.2.1. Hospitals

        9.2.2. Diagnostic Laboratories

        9.2.3. Academic and Research Centers

        9.2.4. Others

    9.3. Global PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user

10. Global PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region

    10.1. Introduction

    10.2. Global PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Region, 2020-2030

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East and Africa

    10.3. Global PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Region

11. North America PCR and Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    11.1. Introduction

    11.2. North America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        11.2.1. Traditional PCR

        11.2.2. Real-time PCR

        11.2.3. Digital PCR

    11.3. North America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2020-2030

        11.3.1. Instruments

        11.3.2. Reagents

        11.3.3. Consumables

    11.4. North America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2020-2030

        11.4.1. Infectious Diseases Testing

            11.4.1.1. HCV and HBV

            11.4.1.2. Sexually Transmitted Infections

            11.4.1.3. Hospital Acquired Infection

            11.4.1.4. Respiratory Infections

            11.4.1.5. Others

        11.4.2. Oncology Testing

        11.4.3. Genetic Testing

        11.4.4. Others

    11.5. North America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2020-2030

        11.5.1. Hospitals

        11.5.2. Diagnostic Laboratories

        11.5.3. Academic and Research Centers

    11.6. North America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Country, 2020-2030

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        11.7.1. By Technology

        11.7.2. By Product

        11.7.3. By Application

        11.7.4. By End-user

        11.7.5. By Country

12. Europe PCR and Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    12.1. Introduction

    12.2. Europe PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        12.2.1. Traditional PCR

        12.2.2. Real-time PCR

        12.2.3. Digital PCR

    12.3. Europe PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2020-2030

        12.3.1. Instruments

        12.3.2. Reagents

        12.3.3. Consumables

    12.4. Europe PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2020-2030

        12.4.1. Infectious Diseases Testing

            12.4.1.1. HCV and HBV

            12.4.1.2. Sexually Transmitted Infections

            12.4.1.3. Hospital Acquired Infection

            12.4.1.4. Respiratory Infections

            12.4.1.5. Others

        12.4.2. Oncology Testing

        12.4.3. Genetic Testing

        12.4.4. Others

    12.5. Europe PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2020-2030

        12.5.1. Hospitals

        12.5.2. Diagnostic Laboratories

        12.5.3. Academic and Research Centers

    12.6. Europe PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2020-2030

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        12.7.1. By Technology

        12.7.2. By Product

        12.7.3. By Application

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    13.1. Introduction

    13.2. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        13.2.1. Traditional PCR

        13.2.2. Real-time PCR

        13.2.3. Digital PCR

    13.3. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2020-2030

        13.3.1. Instruments

        13.3.2. Reagents

        13.3.3. Consumables

    13.4. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2020-2030

        13.4.1. Infectious Diseases Testing

            13.4.1.1. HCV and HBV

            13.4.1.2. Sexually Transmitted Infections

            13.4.1.3. Hospital Acquired Infection

            13.4.1.4. Respiratory Infections

            13.4.1.5. Others

        13.4.2. Oncology Testing

        13.4.3. Genetic Testing

        13.4.4. Others

    13.5. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2020-2030

        13.5.1. Hospitals

        13.5.2. Diagnostic Laboratories

        13.5.3. Academic and Research Centers

    13.6. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2020-2030

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia and New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        13.7.1. By Technology

        13.7.2. By Product

        13.7.3. By Application

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America PCR and Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    14.1. Introduction

    14.2. Latin America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        14.2.1. Traditional PCR

        14.2.2. Real-time PCR

        14.2.3. Digital PCR

    14.3. Latin America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2020-2030

        14.3.1. Instruments

        14.3.2. Reagents

        14.3.3. Consumables

    14.4. Latin America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2020-2030

        14.4.1. Infectious Diseases Testing

            14.4.1.1. HCV and HBV

            14.4.1.2. Sexually Transmitted Infections

            14.4.1.3. Hospital Acquired Infection

            14.4.1.4. Respiratory Infections

            14.4.1.5. Others

        14.4.2. Oncology Testing

        14.4.3. Genetic Testing

        14.4.4. Others

    14.5. Latin America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2020-2030

        14.5.1. Hospitals

        14.5.2. Diagnostic Laboratories

        14.5.3. Academic and Research Centers

    14.6. Latin America PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2020-2030

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        14.7.1. By Technology

        14.7.2. By Product

        14.7.3. By Application

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    15.1. Introduction

    15.2. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2020-2030

        15.2.1. Traditional PCR

        15.2.2. Real-time PCR

        15.2.3. Digital PCR

    15.3. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2020-2030

        15.3.1. Instruments

        15.3.2. Reagents

        15.3.3. Consumables

    15.4. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2020-2030

        15.4.1. Infectious Diseases Testing

            15.4.1.1. HCV and HBV

            15.4.1.2. Sexually Transmitted Infections

            15.4.1.3. Hospital Acquired Infection

            15.4.1.4. Respiratory Infections

            15.4.1.5. Others

        15.4.2. Oncology Testing

        15.4.3. Genetic Testing

        15.4.4. Others

    15.5. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2020-2030

        15.5.1. Hospitals

        15.5.2. Diagnostic Laboratories

        15.5.3. Academic and Research Centers

    15.6. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2020-2030

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East and Africa

    15.7. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        15.7.1. By Technology

        15.7.2. By Product

        15.7.3. By Application

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Global PCR and Real-time PCR Molecular Diagnostics Market Position Analysis, by Company, 2020

    16.3.  Company Profiles

        16.3.1. Abbott Laboratories

            16.3.1.1. Company Description

            16.3.1.2. Business Overview

            16.3.1.3. Financial Overview

            16.3.1.4. Strategic Overview

            16.3.1.5. SWOT Analysis

        16.3.2. Elekta AB Bio-Rad Laboratories, Inc.

            16.3.2.1. Company Description

            16.3.2.2. Business Overview

            16.3.2.3. Financial Overview

            16.3.2.4. Strategic Overview

            16.3.2.5. SWOT Analysis

        16.3.3. bioMérieux SA

            16.3.3.1. Company Description

            16.3.3.2. Business Overview

            16.3.3.3. Financial Overview

            16.3.3.4. Strategic Overview

            16.3.3.5. SWOT Analysis

        16.3.4. Danaher Corporation

            16.3.4.1. Company Description

            16.3.4.2. Business Overview

            16.3.4.3. Financial Overview

            16.3.4.4. Strategic Overview

            16.3.4.5. SWOT Analysis

        16.3.5. Thermo Fisher Scientific, Inc.

            16.3.5.1. Company Description

            16.3.5.2. Business Overview

            16.3.5.3. Financial Overview

            16.3.5.4. Strategic Overview

            16.3.5.5. SWOT Analysis

        16.3.6. Becton, Dickinson and Company

            16.3.6.1. Company Description

            16.3.6.2. Business Overview

            16.3.6.3. Financial Overview

            16.3.6.4. Strategic Overview

            16.3.6.5. SWOT Analysis

        16.3.7. F. Hoffmann-La Roche Ltd

            16.3.7.1. Company Description

            16.3.7.2. Business Overview

            16.3.7.3. Financial Overview

            16.3.7.4. Strategic Overview

            16.3.7.5. SWOT Analysis

        16.3.8. QIAGEN N.V.

            16.3.8.1. Company Description

            16.3.8.2. Business Overview

            16.3.8.3. Financial Overview

            16.3.8.4. Strategic Overview

            16.3.8.5. SWOT Analysis

        16.3.9. Hologic, Inc.

            16.3.9.1. Company Description

            16.3.9.2. Business Overview

            16.3.9.3. Financial Overview

            16.3.9.4. Strategic Overview

            16.3.9.5. SWOT Analysis

        16.3.10. GRIFOLS, S.A.

            16.3.10.1. Company Description

            16.3.10.2. Business Overview

            16.3.10.3. Financial Overview

            16.3.10.4. Strategic Overview

            16.3.10.5. SWOT Analysis

        16.3.11. Genomic Health

            16.3.11.1. Company Description

            16.3.11.2. Business Overview

            16.3.11.3. Financial Overview

            16.3.11.4. Strategic Overview

            16.3.11.5. SWOT Analysis

        16.3.12. Seegene, Inc.

            16.3.12.1. Company Description

            16.3.12.2. Business Overview

            16.3.12.3. Financial Overview

            16.3.12.4. Strategic Overview

            16.3.12.5. SWOT Analysis

17. Research Methodology

18. Acronyms and Assumptions Used

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

PCR and Real-time PCR Molecular Diagnostics Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030